Premium
mTOR Inhibitors: A Myth, a Cure for Cancer or Something in Between?
Author(s) -
Wong G.,
Chapman J. R.,
Craig J. C.
Publication year - 2012
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2012.04007.x
Subject(s) - medicine , immunosuppression , cancer , transplantation , pi3k/akt/mtor pathway , skin cancer , sirolimus , kidney transplantation , organ transplantation , kidney cancer , oncology , apoptosis , biochemistry , chemistry
This editorial summarizes the current evidence and the authors' perspective regarding the role of mTOR inhibitors and cancer in kidney transplant recipients. See article by Campbell et al on page 1146.